SPY381.42-5.12 -1.32%
DIA312.99-1.20 -0.38%
IXIC12,997.75-361.04 -2.70%

US, UK, Canada, Europe Start Novavax COVID-19 Vaccine Rolling Reviews

· 02/05/2021 00:06

05:04 AM EST, 02/05/2021 (MT Newswires) -- Novavax (NVAX) said Thursday regulatory bodies in the US and multiple other countries have started rolling reviews of its COVID-19 vaccine, NVX-CoV2373.

The US Food and Drug Administration, the European Medicines Agency, Health Canada and Britain's Medicines and Healthcare products Regulatory Agency all started the rolling review process for Novavax's protein-based vaccine, the biotech firm said.

Novavax said the rolling reviews will speed up evaluation of the vaccine, which is simultaneously being tested in phase 3 trials in the US and UK as COVID-19 therapy.

Price: 281.52, Change: +0.60, Percent Change: +0.21